Curis Lifesciences IPO Will Open On Nov 07, 2025 And Close On Nov 11, 2025. The ₹27.52 Cr. IPO Is A Fresh Offer. Curis Lifesciences IPO Price Band is Set At ₹120 to ₹128 Per share.
The Allotment Will Be Finalized On Nov 12, 2025 and Listing date is Expected on The NSE SME By Nov 14, 2025. Investor Quota like 33.30% Retail 14.33% HNI 47.35% QIB and Market Maker is 5.02% Category.
Financial Year 2025 Company Posted a total income ₹49.65 Cr. and A Net Profit of ₹6.11 Cr. Showing Strong Growth From The Previous Year. Based On Financial, The IPO Looks Promising For Long-term Investors.
Curis Lifesciences IPO Dates & Price Band Details
| Open Date | Nov 07, 2025 |
|---|---|
| Close Date | Nov 11, 2025 |
| Price Band | ₹120 to ₹128 per share |
| Face Value | ₹10 per equity share |
| Lot Size | 1,000 Shares |
| Type of Issue | Fresh Issue |
| Total Issue Size | 21,50,000 shares (Approx ₹27.52 Cr) |
| Market Maker | 1,08,000 shares (Approx ₹1.38 Cr) |
| Net Issue to the Public | 20,42,000 shares (Approx ₹26.14 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing Exchange | NSE SME |
| Retail Investor Quota | 33.30% |
| NII (HNI) Quota | 14.33% |
| QIB Quota | 47.35% |
| Anchor Investor List | Click Here |
| DRHP (Draft Prospectus) | Click Here |
| RHP (Final Prospectus) | Click Here |
About Curis Lifesciences Limited
Our Company was originally incorporated on June 2, 2010 “Curis Lifesciences Limited” as pharma manufacturer, specializing in manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral Liquid, Sterile Ophthalmic Ointments.
1. Loan License manufacturing: our company carry outs manufacturing under Loan License arrangement, where all raw materials and excipients are procured and delivered by the client. Further the client provides us with necessary supporting documents and formulations.
2. Contract Manufacturing: our company carry outs manufacturing under Contract Manufacturing arrangement, where our Company would be responsible for procuring and handling all ingredients, raw materials, and packaging materials.
3. Direct Export/Own Brand Manufacturing: our company manufactures products registered by itself in foreign country and sells the said products in foreign country through its distribution network.
Our past and present clientele includes renowned pharma marketers and manufactures namely Arova Pharma, Express Pharmaceuticals Private Limited, Angel Biogenics Private Limited, Centurion Healthcare Private Limited, Costcon Healthcare LLP, J B Chemicals and Pharmaceuticals Limited, Venus international, Makers Laboratories Ltd and Troikaa Pharmaceuticals Limited etc.
Our Competitive Strengths
Experienced Promoters and Management Team.
Wide range of Products.
Strategic Location of Manufacturing Facility
Scalable Business Model.
Quality assurance.
Curis Lifesciences IPO Market Lot Size
The Minimum Lot Size For The Curis Lifesciences IPO is 1,000 Shares, Requiring An Application Amount of ₹2,56,000 and in multiples of 2,000 For Retail Investors. Investors Must Apply in Multiples of The Lot Size.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 2,000 | ₹2,56,000 |
| Retail Maximum | 2 | 2,000 | ₹2,56,000 |
| S-HNI Minimum | 3 | 3,000 | ₹3,84,000 |
| S-HNI Maxmum | 7 | 7,000 | ₹8,96,000 |
| B-HNI Minimum | 8 | 8,000 | ₹10,24,000 |
Objects Of The Issue
Capital Expenditure towards Upgradation/Improvement of our existing Manufacturing Facilities.
Capital Expenditure towards Construction of a Storage Facility.
Pre-payment/Repayment of outstanding Secured Loans.
Product Registrations in other countries
Funding our Working Capital Requirements.
General Corporate Purpose.
Curis Lifesciences IPO Allotment & Listing Date
Curis Lifesciences IPO Will Open on Nov 07 and Close on Nov 11, 2025. The allotment is Expected on Nov 12, With the Listing Scheduled on NSE SME For Nov 14, 2025 (More information below table).
| Anchor Investor Bidding | Thu, Oct 06, 2025 |
|---|---|
| IPO Open | Fri, Oct 07, 2025 |
| IPO Close | Tue, Nov, 11, 2025 |
| Allotment Finalisation | Wed, Nov, 12, 2025 |
| Refunds / Unblocking | Thu, Nov, 13, 2025 |
| Shares Credited to Demat | Thu, Nov, 13, 2025 |
| Listing Date | Fri, Nov, 14, 2025 |
Curis Lifesciences IPO Financial Report (FY 2025)
Curis Lifesciences Reported a Total Income of ₹49.65 Cr. in FY 2025, Slightly up From ₹35.87 Cr. in FY 2024. The Company Net Profit Also Rose to ₹6.11 Cr. From ₹4.87 Cr. in the Previous Year Showing Consistent Financial Growth Ahead of its IPO. (More information below table).
| Period Ended | 31 Jul 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 56.29 | 42.53 | 33.88 | 29.75 |
| Total Income | 19.51 | 49.65 | 35.87 | 36.42 |
| Profit After Tax | 2.87 | 6.11 | 4.87 | 1.88 |
| EBITDA | 4.24 | 9.54 | 8.39 | 3.28 |
| NET Worth | 19.10 | 16.23 | 5.87 | 1.01 |
| Reserves and Surplus | 13.16 | 10.29 | 5.37 | 0.51 |
| Total Borrowing | 15.32 | 15.62 | 17.09 | 16.19 |
| Amount in ₹ Crore |
Curis Lifesciences IPO Valuation Report – FY 2025 (KPI)
Check Detailed Curis Lifesciences IPO Valuation Metrics for FY 2025, including EPS, P/E Ratio, RoNW, NAV, ROCE, and other key financial indicators. These Ratios help Investors Assess the Company financial Health & Valuation Before applying for The IPO. (More information below table).
| KPI | Value |
|---|---|
| Return on Equity (ROE) | 55.25% |
| Return on Capital Employed (ROCE) | 27.83% |
| EBITDA Margin | 19.41% |
| PAT Margin | 12.43% |
| Debt-to-Equity Ratio | 0.96 |
| Earnings Per Share (EPS) | 10.29 |
| Price to Earnings Ratio (P/E) | 12.44 |
| Return on Net Worth (RoNW) | 37.62% |
| Net Asset Value (NAV) | 27.34 |
Comparison of Accounting Ratios with Industry Peers
| Name of Company | Current Market Price (₹) | Face Value (₹) | EPS Basic) | PE | RONW (%) | NAV per share (₹) | Total Income (₹ in lakhs) |
|---|---|---|---|---|---|---|---|
| Curis Lifesciences Limited | [●] | 10 | 10.29 | 12.43 | 37.62 | 27.34 | 4964.50 |
| Sotac Pharmaceuticals Limited | 128 | 10 | 4.32 | 18.30 | 9.00% | 47.99 | 6475.92 |
| Lincoln Pharmaceuticals Limited | 528 | 10 | 41.11 | 12.21 | 12.27% | 335.34 | 64570.72 |
Also Read: Shining Tools IPO:Listing Price, GMP, Date, Review, Details
Also Read : Finbud Financial IPO : Listing Price, GMP, Date, Review, Details
Our Company Promoters
1. Mr. Dharmesh Dasharathbhai Patel
2. Mr. Siddhant Jayantibhai Pawasia
3. Mr. Piyush Gordhanbhai Antala
4. Mr. Jaimik Mansukhbhai Patel
Also Read : Curis Lifesciences IPO GMP, Grey Market Premium Today
Curis Lifesciences Company Contact Details
Curis Lifesciences Ltd.
PF-23, GIDC Sanand – II,Industrial Estate,
Sanand Ahmedabad, Gujarat, 382110
Tel: +91 99045 22543
Email: cs@curisls.com
Website: https://curisls.com/
Curis Lifesciences Lead Manager
FINAAX CAPITAL ADVISORS PRIVATE LIMITED
Address: B-401, The First, B/s Keshavbaug Party Plot,
I I M, Ahmedabad-380015, Gujarat, India
Telephone Number: +91 94295 50695 / 9537594321
Email Id: info@finaaxcapital.com
Website: www.finaaxcapital.com
Curis Lifesciences IPO Registrar
MUFG INTIME INDIA PRIVATE LIMITED
Address: C-101, 247 Park, 1st Floor,
L B S Marg, Vikhroli (West),
Mumbai 400083, (Maharashtra), India.
Telephone:+91-8108114949
Email ID: shreejiglobal.smeipo@in.mpms.mufg.com
Website: https://in.mpms.mufg.com
Curis Lifesciences IPO FAQs
Question 1: What is the Curis Lifesciences IPO?
Answer 1: Curis Lifesciences IPO is a SME IPO of 21,50,000 equity shares of the face value of ₹10 approximately up to ₹27.52 Cr. The issue is price at ₹120 to ₹128 per share.
The Curis Lifesciences IPO opens on Nov 07, 2025 and closes on Nov 11, 2025.
MUFG INTIME INDIA PRIVATE LIMITED is the registrar for the IPO. The shares to be listed on NSE SME.
Question 2: How to apply in Curis Lifesciences IPO through Groww?
Answer 2: Groww customers can apply online in Curis Lifesciences IPO using UPI as a payment gateway. Groww customers can apply in Curis Lifesciences IPO by login into Groww (back office) and submitting an IPO application form.
Steps to apply in Curis Lifesciences IPO through Groww –
Visit the Groww website and login to Groww.
Go to Main Page and click the Products & tools and click IPO tab.
New page Open and Show ‘ Curis Lifesciences IPO’ click the ‘Apply’ button.
Show IPO detail Shares lot Size and Bid Price & click here to Cutoff Price check Box and Continue.
Inter Your UPI id like . 95****299@kotak accept terms and condition click Box and Apply For IPO
groww share payment link Your UPI Mobile Number Pay Payment for IPO Bid to approve the e-mandate successfully submit application .
Question 3: When Curis Lifesciences IPO will open?
Answer 3: The Curis Lifesciences IPO opens on Nov 07, 2025 and closes on Nov 11, 2025.
Question 4: What is the lot size of Curis Lifesciences IPO?
Answer 4: Curis Lifesciences IPO lot size and the minimum order quantity is 1,000 Shares.
Question 5: How to apply for Curis Lifesciences IPO?
Answer 5: You can apply in Curis Lifesciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services. Read more detail about applying IPO online through Groww, Zerodha, Upstox, 5Paisa, Phonepe Share Market, HDFC Bank, and Angel one.
Question 6: When is Curis Lifesciences IPO allotment date?
Answer 6: The Basis of Allotment for Curis Lifesciences IPO will be on Wed, Nov, 12, 2025, and the allotted shares will be credited to your demat account by Thu, Nov, 13, 2025. For Check the Curis Lifesciences IPO allotment status.
Question 7: When is Curis Lifesciences IPO listing date?
Answer 7: The Curis Lifesciences IPO listing date is Nov 14, 2025. The date of Curis Lifesciences IPO listing on Fri, Nov, 14, 2025.
